Unmasking immune reconstitution inflammatory syndrome (IRIS): A report of five cases and review of the literature

Sultan Qaboos University Medical Journal

Volumn 11, Issue 1, 2011, Pages 95-103

  Balkhair, Abdullah ^a   Ahamed, Sudheer ^a   Sankhla, Dilip ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

AIDS; Atypical mycobacterium; Case report; Cryptococcus; Cryptosporidium; HAART; HIV; Immune reconstitution inflammatory syndrome; IRIS; Oman; TB; Toxoplasmosis

Indexed keywords

ATYPICAL MYCOBACTERIUM; CRYPTOSPORIDIUM; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79957946737     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the Euro-SIDA study: an observational study. Lancet 2003; 362:22-9.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
3. Gea-Banacloche JC, Clifford Lane H. Immune reconstitution in HIV infection. Aids 1999; 13 Suppl A: S25-38.
4. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, et al. Immune restoration disease after the treatment of immune-deficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000; 1:107-15.
5. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002; 81:213-27.
6. Shelburne SA, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev 2003; 5:67-79.
7. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18:1615-27.
8. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 2000; 133:447-54.
9. Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM, et al. Immune-restitution disease involving the innate and adaptive response. Clin Infect Dis 2000; 30:882-92.
10. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005; 19:399-406.
11. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006; 42:418-27.
12. Jevtovic DJ, Salemovic D, Ranin J, Pesic I, Zerjav S, Djurkovic-Djakovic O. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2005, 6:140-3.
13. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5:361-73.
14. Cooney EL. Clinical indicators of immune restoration following highly active antiretroviral therapy. Clin Infect Dis 2002; 34:224-33.
15. Woods ML, MacGinley R, Eisen D, Allworth AM. HIV combination therapy: partial immune reconstitution unmasking latent cryptococcal infection. AIDS 1998; 12:1491-4.
16. Skiest DJ, Hester LJ, Hardy RD. Cryptococcal immune reconstitution inflammatory syndrome: Report of four cases in three patients and review of the literature. J Infect 2005; 51:e289-97.
17. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clin Infect Dis 2002; 35:e128-33.
18. Shelburne SA 3rd, Darcourt J, White C Jr, Greenberg SB, Hamil RJ, Atmar RL, et al. The role of immune reconstitution inflammatory syndrome in AIDSrelated Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:1045-52.
19. Shelburne SA, Hamill RJ. Risk of IRIS in patients with opportunistic infections during HAART. Contagion 2005; 2:389-94.
20. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005; 19:1043-9.
21. Tsambiras PE, Larkin JA, Houston SH. Case report. Toxoplasma encephalitis after initiation of HAART. AIDS Read 2001; 11:608-10.
22. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006; 57:167-70.
23. Haddow LJ, Easterbrook PJ, Mosam M, Khanyile NG, Parboosing R, Moodley P, et al. Defining immune reconstitution inflammatory syndrome: Evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis 2009; 49:1424-32.
24. Battegay M, Drechsler H. Immune reconstitution. Curr Opin HIV AIDS 2006; 1:6-61.